Glioblastoma multiforme News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

The global glioblastoma multiforme (GBM) market size to reach USD 1.15 billion by 2024 - PR Newswire (press release)



The global glioblastoma multiforme (GBM) market size to reach USD 1.15 billion by 2024 
PR Newswire (press release)
The global glioblastoma multiforme (GBM) market size to reach USD 1.15 billion by 2024, fueled by the increasing occurrence of cancer in the central nervous system among the ageing population. The market is highly prevalent in the countries of North ...

and more » 


Glioblastoma Multiforme Market Report First-In-Class Matrix Assessment, Target Profiles And Product Innovations ... - Expert Herald



Expert Herald
 
Glioblastoma Multiforme Market Report First-In-Class Matrix Assessment, Target Profiles And Product Innovations ... 
Expert Herald
Glioblastoma Multiforme Market Report is a proficient latest research of the Glioblastoma Multiforme industry comprising of leading manufacturers, product types, and market size revenue forecast. In addition, report sheds light on dominant molecule ...

 


CURE® Magazine Announces Winners of 2017 GBM Heroes® Awards - Business Wire (press release)



Business Wire (press release)
 
CURE® Magazine Announces Winners of 2017 GBM Heroes® Awards 
Business Wire (press release)
CRANBURY, N.J.--(BUSINESS WIRE)--CURE® magazine, the nation's leading consumer digital and print media enterprise focused entirely on patients with cancer, honored Al Musella, D.P.M.; Linda Liau, M.D.; Kay Verble; and Matt Anthony as this year's ...

and more » 


Javelin Mortgage Investment (NYSE:JMI) & DelMar Pharmaceuticals (DMPI) Critical Analysis - The Ledger Gazette



Javelin Mortgage Investment (NYSE:JMI) & DelMar Pharmaceuticals (DMPI) Critical Analysis 
The Ledger Gazette
DelMar Pharmaceuticals logo DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate ...
Comparing Javelin Mortgage Investment (JMI) & DelMar Pharmaceuticals (DMPI) StockNewsTimes

all 3 news articles » 


Your Healthy Family: Charlie Hall's glioblastoma diagnosis - KOAA.com Colorado Springs and Pueblo News



Your Healthy Family: Charlie Hall's glioblastoma diagnosis 
KOAA.com Colorado Springs and Pueblo News
A big part of the #NoShaveNovember push, is to raise awareness of men's health issues like prostate cancer, and colon cancer. Another issue men generally have centers around the habit of simply not going to the doctor for a yearly physical, or even ...

and more » 


RVNC's All Smiles, NVCR Catches Eyes, ACRS Waiting For Xmas Gift, KIDS Growing - Nasdaq



RVNC's All Smiles, NVCR Catches Eyes, ACRS Waiting For Xmas Gift, KIDS Growing 
Nasdaq
On October 26, 2017, the Company reported third quarter financial results. The net losses for the three months ended September 30, 2017, narrowed to $11.5 million or $0.13 per share on revenue of $50 million. This compared with a net loss of $33.6 ...

 


Critical Contrast: Javelin Mortgage Investment (JMI) versus DelMar Pharmaceuticals (DMPI) - The Ledger Gazette



Finance News Daily
 
Critical Contrast: Javelin Mortgage Investment (JMI) versus DelMar Pharmaceuticals (DMPI) 
The Ledger Gazette
DelMar Pharmaceuticals logo DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate ...
Comparing Javelin Mortgage Investment (NYSE:JMI) & DelMar Pharmaceuticals (DMPI) StockNewsTimes
DelMar Pharmaceuticals (DMPI) Given a $12.00 Price Target at HC Wainwright The Lincolnian Online

all 19 news articles » 


Glioblastoma Multiforme (GBM) Market Assessment by Products, Drug Profile forecast for Upcoming years - MilTech



Glioblastoma Multiforme (GBM) Market Assessment by Products, Drug Profile forecast for Upcoming years 
MilTech
Glioblastoma Multiforme (GBM) ? Pipeline Review, H2 provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape. Glioblastoma Multiforme (GBM) Market report provides comprehensive information on the therapeutics under development for ...

and more » 


New report Glioblastoma Multiforme (GBM)-Epidemiology Forecast to 2025 - Medgadget (blog)



New report Glioblastoma Multiforme (GBM)-Epidemiology Forecast to 2025 
Medgadget (blog)
?Glioblastoma multiforme (GBM) ? Epidemiology Forecast To 2025? provides an overview of the epidemiology trends of Glioblastoma multiforme (GBM) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology ...

 


Cancer drug starts clinical trials in human brain-cancer patients - Science Daily



Medical Xpress
 
Cancer drug starts clinical trials in human brain-cancer patients 
Science Daily
It is almost impossible to find and remove all glioblastoma cancer cells in surgery, however, Dudek said. "Glioblastoma multiforme has this feature of spreading silently along the blood vessels inside the brain," he said. "That's a reason why most ...
U. of I. News: Cancer drug starts clinical trials in human brain-cancer patients Newsroom America

all 2 news articles »